IN8bio (INAB)
NASDAQ:INAB
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -2.50M | $ 0.00 | $ -2.50M | $ -1.10M | $ 0.00 |
| Operating Income | $ -19.86M | $ -30.44M | $ -30.34M | $ -28.52M | $ -14.65M |
| EBITDA | $ -17.36M | $ -26.94M | $ -27.51M | $ -27.42M | $ -13.87M |
| Net Income | $ -19.44M | $ -30.44M | $ -30.01M | $ -28.52M | $ -14.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 27.09M | $ 11.12M | $ 21.28M | $ 18.18M | $ 37.02M |
| Total Assets | $ 32.28M | $ 20.94M | $ 33.71M | $ 33.04M | $ 42.22M |
| Total Debt | $ 2.78M | $ 5.03M | $ 4.89M | $ 5.87M | $ 2.41M |
| Net Debt | $ -24.31M | $ -6.09M | $ -16.39M | $ -12.31M | $ -34.61M |
| Total Liabilities | $ 4.72M | $ 6.47M | $ 8.77M | $ 10.31M | $ 4.04M |
| Stockholders' Equity | $ 27.56M | $ 14.48M | $ 24.94M | $ 22.73M | $ 38.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.71M | $ -24.25M | $ -23.94M | $ -27.83M | $ -13.82M |
| Operating Cash Flow | $ -12.71M | $ -24.15M | $ -23.34M | $ -24.12M | $ -13.51M |
| Investing Cash Flow | $ 0.00 | $ -187.00K | $ -600.00K | $ -3.71M | $ -309.00K |
| Financing Cash Flow | $ 28.64M | $ 14.18M | $ 27.04M | $ 8.99M | $ 32.95M |